{"biological_condition":["Treatment: 300 nM Crizotinib for 3 hrs"],"cell_line":["SU-DHL-1 (Anaplastic large cell lymphoma)"],"identifier":["EXP053282","GSE117164","GSM3272744"],"jaspar_id":["MA0144.2"],"prediction_models":["DAMO"],"tf_id":"EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3","tf_name":"STAT3","tfbs":[{"DAMO":[{"adj_centrimo_pvalue":-5.90348788890139,"distance_threshold":"56","jaspar_id":"MA0144","jaspar_version":"2","score_threshold":"88.6","total_tfbs":"535","model_detail":"","bed_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.bed","fasta_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.fa","summary_plot_url":"https://unibind.uio.no/static/data/20220914/macs/DAMO/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3/EXP053282.SU-DHL-1_Anaplastic_large_cell_lymphoma.STAT3.MA0144.2.damo.png"}]}],"total_peaks":"1589"}